PhotoDetection Systems (PDS) introduced its NeuroPET scanner to the molecular imaging community at the recent 2009 SNM annual meeting in Toronto.
NeuroPET's wavelength-shifting fiber technology enables high-sensitivity and superior spatial resolution. Its compact/portable design requires no special site preparation, according to the Boxboro, Mass.-based company.
PDS said its scanner uses low doses of 18F and 11C tracers to image metabolism, amyloid and dopaminergic binding in neurological diseases. The tracers are known to be helpful in imaging challenging and costly diseases, such as Alzheimer's, neuro-oncology, epilepsy, Parkinson's and neuro-psychiatric disorders.